This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Long-Term Care Insurer Penn Treaty American Fails

Pennsylvania regulators are mulling options that include selling or liquidating long-term care insurer Penn Treaty American Corp. (PTYA), two days after a judge ordered two of its subsidiaries into rehabilitation.

According to court order issued by the Commonwealth Court of Pennsylvania, the rehabilitator will continue to pay claims on all existing policies held by Penn Treaty Network America Insurance Co. and its much smaller subsidiary, American Network Insurance Co. Rosanne Placey, a spokesperson for the Pennsylvania Insurance Commissioner, said that in these very early stages their goal is to decide what is viable for the company.

No new policies will be sold under the rehabilitation although the intention is to renew existing policies, she said.

Both companies are monoline insurers in the long-term care insurance market. When Penn Treaty entered the long-term care insurance market in the 1990s it had a reputation for very aggressive pricing in order to rapidly build up its business. Placey explained that policies written prior to 2000 were underpriced and the company had difficulty getting approval for rate increases from the various states in which it sold policies.

Placey explained that pricing difficulties across the industry in the past few years, as the definition of long-term care and the expectations of its policyholders evolved, had a negative impact on the company.

She said the company's existing financial difficulties leading only worsened in the current economic environment, when it became impossible to raise new capital.

According to its third-quarter statutory financial statement, Penn Treaty lost $2.4 million for the first nine months of the year and had negative capital of $44.8 million at Sept. 30. From Jan. 1 to Sept. 30, capital had declined $11 million from unrealized capital losses and $54.5 million from a decrease in its liability for reinsurance in unauthorized companies.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $110.51 -1.60%
FB $88.17 -1.90%
GOOG $605.84 -1.40%
TSLA $245.72 -0.80%
YHOO $32.55 2.50%

Markets

Chart of I:DJI
DOW 16,374.76 +23.38 0.14%
S&P 500 1,951.13 +2.27 0.12%
NASDAQ 4,733.4970 -16.4820 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs